Prefecture-specific prevalence of overweight/obesity is associated with regional variation in the incidence of treated ESKD in Japan
Authors:
Open Access
- 8 October 2022
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 27 (2) , 132-140
Abstract
Background: Overweight/obesity is a significant risk factor for chronic kidney disease and end-stage kidney disease (ESKD) in the general population. This study evaluated the impact of sex- and prefecture-specific prevalence of overweight/obesity on standardized incidence rates (SIRs) of treated ESKD in Japan. Methods: We conducted an ecological study of all prefectures in Japan (n = 47) using data from the Japanese Society of Dialysis Therapy, national census, the NDB Open Data, and the Statistics of Physicians, Dentists and Pharmacists. We calculated the prevalence of overweight/obesity and proteinuria, standardized mortality ratio, and ratio of nephrology specialists for each prefecture, and explored associations of these variables with sex- and prefecture-specific SIRs of treated ESKD using bivariate association analysis, multiple regression analysis, and structural equation modeling (SEM). Results: Prefecture-specific SIRs ranged from 0.72 to 1.24 for men and 0.69–1.41 for women. Prefecture-specific SIRs were significantly correlated with both the prevalence of overweight/obesity and prevalence of proteinuria. The prevalence of overweight/obesity showed direct, positive, and significant associations with prefecture-specific SIRs in men (standardized estimate (β) = 0.43, p < 0.001) and women (β = 0.40, p < 0.001). The prevalence of proteinuria showed a significant association with prefecture-specific SIRs only in women (β = 0.33, p = 0.01). The SEM models explained 26% of the variance in SIR for men and 28% for women. Conclusions: Our findings provide evidence that the prefecture-specific prevalence of overweight/obesity in Japan can explain regional variation in prefecture-specific SIRs of treated ESKD in both sexes.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP18K08202)
- Ministry of Health, Labour and Welfare (22FD01001)
This publication has 32 references indexed in Scilit:
- Cause‐Specific Excess Mortality Among Dialysis Patients: Comparison With the General Population in JapanTherapeutic Apheresis and Dialysis, 2012
- High Mortality Rate of Infectious Diseases in Dialysis Patients: A Comparison With the General Population in JapanTherapeutic Apheresis and Dialysis, 2012
- Use of Japanese Society for Dialysis Therapy Dialysis Tables to Compare the Local and National Incidence of DialysisTherapeutic Apheresis and Dialysis, 2012
- Cost-effectiveness of chronic kidney disease mass screening test in JapanClinical and Experimental Nephrology, 2011
- Evidence-based Practice Guideline for the Treatment of CKDClinical and Experimental Nephrology, 2009
- Different regional dynamics of end‐stage renal disease in Japan by different causesNephrology, 2005
- Body mass index and the risk of development of end-stage renal disease in a screened cohortKidney International, 2004
- Renoprotective action of statin estimated from mapping renal failure in JapanKidney International, 2004
- Maps of end-stage renal disease and amounts of angiotensin-converting enzyme inhibitors prescribed in JapanKidney International, 2003
- Proteinuria and the risk of developing end-stage renal diseaseKidney International, 2003